The Market Reports

Index

1 Conjugate Vaccine Market Overview
1.1 Product Overview and Scope of Conjugate Vaccine
1.2 Conjugate Vaccine Segment by Type
1.2.1 Global Conjugate Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine Segment by End Users
1.3.1 Global Conjugate Vaccine Sales Comparison by End Users: (2021-2027)
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Conjugate Vaccine Revenue 2016-2027
1.4.2 Global Conjugate Vaccine Sales 2016-2027
1.4.3 Conjugate Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Conjugate Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Conjugate Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Conjugate Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Conjugate Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Conjugate Vaccine Market Competitive Situation and Trends
2.5.1 Conjugate Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Conjugate Vaccine Players Market Share by Revenue
2.5.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Conjugate Vaccine Retrospective Market Scenario by Region
3.1 Global Conjugate Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Conjugate Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Conjugate Vaccine Market Facts & Figures by Country
3.3.1 North America Conjugate Vaccine Sales by Country
3.3.2 North America Conjugate Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Conjugate Vaccine Market Facts & Figures by Country
3.4.1 Europe Conjugate Vaccine Sales by Country
3.4.2 Europe Conjugate Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Conjugate Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Conjugate Vaccine Sales by Region
3.5.2 Asia Pacific Conjugate Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Conjugate Vaccine Market Facts & Figures by Country
3.6.1 Latin America Conjugate Vaccine Sales by Country
3.6.2 Latin America Conjugate Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Conjugate Vaccine Sales by Country
3.7.2 Middle East and Africa Conjugate Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Conjugate Vaccine Historic Market Analysis by Type
4.1 Global Conjugate Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Conjugate Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Conjugate Vaccine Price by Type (2016-2021)

5 Global Conjugate Vaccine Historic Market Analysis by End Users
5.1 Global Conjugate Vaccine Sales Market Share by End Users (2016-2021)
5.2 Global Conjugate Vaccine Revenue Market Share by End Users (2016-2021)
5.3 Global Conjugate Vaccine Price by End Users (2016-2021)

6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Conjugate Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Conjugate Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Conjugate Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Walvax Biotechnology Conjugate Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Royal (Wuxi) Bio-Pharmaceutical
6.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio
6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.7 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bharat Biotech Conjugate Vaccine Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Zhifei Biologic
6.8.1 Zhifei Biologic Corporation Information
6.8.2 Zhifei Biologic Description and Business Overview
6.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Zhifei Biologic Conjugate Vaccine Product Portfolio
6.8.5 Zhifei Biologic Recent Developments/Updates

7 Conjugate Vaccine Manufacturing Cost Analysis
7.1 Conjugate Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Conjugate Vaccine
7.4 Conjugate Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Conjugate Vaccine Distributors List
8.3 Conjugate Vaccine Customers

9 Conjugate Vaccine Market Dynamics
9.1 Conjugate Vaccine Industry Trends
9.2 Conjugate Vaccine Growth Drivers
9.3 Conjugate Vaccine Market Challenges
9.4 Conjugate Vaccine Market Restraints

10 Global Market Forecast
10.1 Conjugate Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Conjugate Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Conjugate Vaccine by Type (2022-2027)
10.2 Conjugate Vaccine Market Estimates and Projections by End Users
10.2.1 Global Forecasted Sales of Conjugate Vaccine by End Users (2022-2027)
10.2.2 Global Forecasted Revenue of Conjugate Vaccine by End Users (2022-2027)
10.3 Conjugate Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Conjugate Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Conjugate Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Conjugate Vaccine Sales (Million Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Conjugate Vaccine Sales (Million Unit) Comparison by End Users (2021-2027)
Table 3. Global Conjugate Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Conjugate Vaccine Covered in This Study
Table 5. Global Conjugate Vaccine Sales (Million Unit) of Key Manufacturers (2016-2021)
Table 6. Global Conjugate Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Conjugate Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Conjugate Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Conjugate Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Conjugate Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjugate Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Conjugate Vaccine Sales by Region (2016-2021) & (Million Unit)
Table 16. Global Conjugate Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Conjugate Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit)
Table 19. North America Conjugate Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Conjugate Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit)
Table 23. Europe Conjugate Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Conjugate Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Conjugate Vaccine Sales by Region (2016-2021) & (Million Unit)
Table 27. Asia Pacific Conjugate Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Conjugate Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Conjugate Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit)
Table 31. Latin America Conjugate Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Conjugate Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit)
Table 35. Middle East and Africa Conjugate Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Conjugate Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Conjugate Vaccine Sales (Million Unit) by Type (2016-2021)
Table 39. Global Conjugate Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Conjugate Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Conjugate Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Conjugate Vaccine Price (USD/Unit) by Type (2016-2021)
Table 43. Global Conjugate Vaccine Sales (Million Unit) by End Users (2016-2021)
Table 44. Global Conjugate Vaccine Sales Market Share by End Users (2016-2021)
Table 45. Global Conjugate Vaccine Revenue (Million US$) by End Users (2016-2021)
Table 46. Global Conjugate Vaccine Revenue Share by End Users (2016-2021)
Table 47. Global Conjugate Vaccine Price (USD/Unit) by End Users (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Conjugate Vaccine Product
Table 52. Pfizer Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. GSK Conjugate Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Conjugate Vaccine Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Merck Corporation Information
Table 64. Merck Description and Business Overview
Table 65. Merck Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Merck Conjugate Vaccine Product
Table 67. Merck Recent Developments/Updates
Table 68. Walvax Biotechnology Corporation Information
Table 69. Walvax Biotechnology Description and Business Overview
Table 70. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Walvax Biotechnology Conjugate Vaccine Product
Table 72. Walvax Biotechnology Recent Developments/Updates
Table 73. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 74. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 75. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 77. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 78. Bharat Biotech Corporation Information
Table 79. Bharat Biotech Description and Business Overview
Table 80. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bharat Biotech Conjugate Vaccine Product
Table 82. Bharat Biotech Recent Developments/Updates
Table 83. Zhifei Biologic Corporation Information
Table 84. Zhifei Biologic Description and Business Overview
Table 85. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Zhifei Biologic Conjugate Vaccine Product
Table 87. Zhifei Biologic Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Conjugate Vaccine Distributors List
Table 91. Conjugate Vaccine Customers List
Table 92. Conjugate Vaccine Market Trends
Table 93. Conjugate Vaccine Growth Drivers
Table 94. Conjugate Vaccine Market Challenges
Table 95. Conjugate Vaccine Market Restraints
Table 96. Global Conjugate Vaccine Sales Forecast by Type (2022-2027) & (Million Unit)
Table 97. Global Conjugate Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Conjugate Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Conjugate Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Conjugate Vaccine Sales Forecast by End Users (2022-2027) & (Million Unit)
Table 101. Global Conjugate Vaccine Sales Market Share Forecast by End Users (2022-2027)
Table 102. Global Conjugate Vaccine Revenue Forecast by End Users (2022-2027) & (US$ Million)
Table 103. Global Conjugate Vaccine Revenue Market Share Forecast by End Users (2022-2027)
Table 104. Global Conjugate Vaccine Sales Forecast by Region (2022-2027) & (Million Unit)
Table 105. Global Conjugate Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Conjugate Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Conjugate Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Conjugate Vaccine
Figure 2. Global Conjugate Vaccine Market Share by Type in 2020 & 2027
Figure 3. Hib Vaccine Product Picture
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Pneumococcal Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Conjugate Vaccine Market Share by End Users in 2020 & 2027
Figure 8. Children
Figure 9. Adult
Figure 10. Global Conjugate Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Conjugate Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Conjugate Vaccine Sales 2016-2027 (Million Unit)
Figure 13. Global Conjugate Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Conjugate Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global Conjugate Vaccine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Conjugate Vaccine Players: Market Share by Revenue in 2020
Figure 17. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Conjugate Vaccine Sales Market Share by Region (2016-2021)
Figure 19. Global Conjugate Vaccine Sales Market Share by Region in 2020
Figure 20. Global Conjugate Vaccine Revenue Market Share by Region (2016-2021)
Figure 21. Global Conjugate Vaccine Revenue Market Share by Region in 2020
Figure 22. U.S. Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Conjugate Vaccine by Type (2016-2021)
Figure 47. Sales Market Share of Conjugate Vaccine by End Users (2016-2021)
Figure 48. Sales Market Share of Conjugate Vaccine by End Users in 2020
Figure 49. Revenue Share of Conjugate Vaccine by End Users (2016-2021)
Figure 50. Revenue Share of Conjugate Vaccine by End Users in 2020
Figure 51. Manufacturing Cost Structure of Conjugate Vaccine
Figure 52. Manufacturing Process Analysis of Conjugate Vaccine
Figure 53. Conjugate Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed